Potential Synergy Low-dose naltrexone (LDN) is another treatment option for reducing glial cell activation
Recovery from brain injury and stroke Stroke recovery support: Reduces ischemic damage (lack of oxygen) Enhances neuronal survival in penumbra (border zone) Supports neuroplasticity for functional recovery Improves rehabilitation outcomes Accelerates cognitive function return Traumatic brain injury (TBI): Reduces acute inflammation Protects neurons from secondary injury Supports tissue repair Enhances recovery of cognitive function Reduces long-term neurological deficits Russian clinical use: Administered post-stroke in hospitals Part of rehabilitation protocols Often combined with other peptides Decades of clinical experience Considered standard neuroprotective agent Mechanism in brain injury: Reduces excitotoxicity (glutamate-induced damage) Enhances mitochondrial function in stressed neurons Upregulates neurotrophic factors (BDNF, NGF) Reduces oxidative stress Supports blood-brain barrier repair Combination with other healing peptides: BPC-157 : Systemic tissue healing , angiogenesis TB-500 : Cell migration, tissue repair Pinealon: Brain-specific neuroprotection See best peptides for injury recovery and BPC-157 vs TB-500
[DOI] [PubMed] [Google Scholar] 160.Thomou T, Mori MA, Dreyfuss JM, Konishi M, Sakaguchi M, Wolfrum C, et al
Richele Corrado, director of Walter Reed's Internal Medicine Comprehensive Weight Management Program
MontagnaPSacquegnaTMartinelliPCortelliPBresolinNMoggioMet al
I have formulated MTHFR Pathways , which contains all of the above-mentioned ingredients and may be helpful in maintaining healthy homocysteine levels.* Read more about MTHFR and Hashimotos here
